Tatva ChintanQ3 FY24

Tatva Chintan Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,660.8P/E: 60.8Market Cap: ₹3.9K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

No

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • PTC segment: Organic volume growth of 10-15% per year historically; 2023 may see no volume growth due to sharp product price drops; topline degrowth expected in 2023; business stable with secured large MNC customers for 2024.
  • PASC and SDA segments: Expected to drive future growth with commercialization starting August 2024; incremental revenue of Rs. 200 crores from PASC and Rs. 80-100 crores from SDA over next 3 years.
  • Overall growth guidance: At least 70% revenue growth anticipated in FY25 driven by volume growth and new products; value erosion due to lower product pricing considered in forecasts.
  • Capacity Utilization: Full utilization expected from July-August 2024; new CAPEX of about Rs. 70 crores underway to expand capacity.
  • Longer-term: Growth supported by sustained export demand (~70% of revenue from exports); SDA segment demand to benefit post-2027 with BS-7 emission norms implementation.

See what Tatva Chintan management said on margin guidance — free account, 30 seconds.

Fundraise plans

The provided transcript and document pages do not mention any current or planned fundraising activities through debt or equity. Key points related to funding are: - The company is undertaking a CAPEX of Rs. 70 crores for expansion, funded from internal or existing resources (no mention of external fundraising). - Earlier CAPEX of about Rs. 150-250 crores was done during the IPO, but no new equity or debt raising is indicated. - The company is confident about meeting future growth with existing capacity expansions without mentioning fresh fundraising. - No specific references to raising funds through debt or equity in the near future were made during the call or presentation. Hence, no current or future fundraising through debt or equity is disclosed in this material.

See what Tatva Chintan management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company announced a capital expenditure (CAPEX) of Rs. 70 crore, expected to be commercialized by October 2024.
  • This CAPEX is for an add-on facility at the Dahej site, including 150 KL reactors and a separate distillation plant, aiming to support commercialization of new products in the PASC (Pharma and Agro intermediates) segment.
  • The Rs. 70 crore investment is to capture growth opportunities and avoid delivery mismatches, expected to generate incremental revenue of Rs. 95-100 crore.
  • The company also received environmental clearance for a greenfield project at Jolva, Dahej, with construction planned to start in 2025.
  • Further CAPEX was about Rs. 250 crore from IPO proceeds, leading to asset turn improvements and capacity expansion across PTC, SDA, and PASC segments.
  • Additional continuous flow reactors are being added at the lab and pilot scales as part of ongoing development projects.

Track Tatva Chintan — get its next earnings analysis in your feed

How does Tatva Chintan rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisTatva Chintan
Rev 3Mar 3

How does Tatva Chintan rank in Chemicals & Petrochemicals?

Compare Tatva Chintan against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →